Department of Pharmacy , Uppsala University , Uppsala Biomedical Center P.O. Box 580, SE-751 23 Uppsala , Sweden.
Drug Delivery, Disposition and Dynamics , Monash Institute of Pharmaceutical Sciences, Monash University , 381 Royal Parade , Parkville , Victoria 3052 , Australia.
Mol Pharm. 2018 Oct 1;15(10):4733-4744. doi: 10.1021/acs.molpharmaceut.8b00699. Epub 2018 Sep 7.
In this study we investigated lipolysis-triggered supersaturation and precipitation of a set of model compounds formulated in lipid-based formulations (LBFs). The purpose was to explore the relationship between precipitated solid form and inherent physicochemical properties of the drug. Eight drugs were studied after formulation in three LBFs, representing lipid-rich (extensively digestible) to surfactant-rich (less digestible) formulations. In vitro lipolysis of drug-loaded LBFs were conducted, and the amount of dissolved and precipitated drug was quantified. Solid form of the precipitated drug was characterized with polarized light microscopy (PLM) and Raman spectroscopy. A significant solubility increase for the weak bases in the presence of digestion products was observed, in contrast to the neutral and acidic compounds for which the solubility decreased. The fold-increase in solubility was linked to the degree of ionization of the weak bases and thus their attraction to free fatty acids. A high level of supersaturation was needed to cause precipitation. For the weak bases, the dose number indicated that precipitation would not occur during lipolysis; hence, these compounds were not included in further studies. The solid state analysis proved that danazol and griseofulvin precipitated in a crystalline form, while niclosamide precipitated as a hydrate. Felodipine and indomethacin crystals were visible in the PLM, whereas the Raman spectra showed presence of amorphous drug, indicating amorphous precipitation that quickly crystallized. The solid state analysis was combined with literature data to allow analysis of the relationship between solid form and the physicochemical properties of the drug. It was found that low molecular weight and high melting temperature increases the probability of crystalline precipitation, whereas precipitation in an amorphous form was favored by high molecular weight, low melting temperature, and positive charge.
在这项研究中,我们研究了一系列模型化合物在脂质制剂(LBFs)中引发的脂肪分解触发的过饱和和沉淀。目的是探索沉淀的固体形式与药物固有物理化学性质之间的关系。在三种 LBF 中对八种药物进行了制剂后研究,代表了富含脂质(可充分消化)和富含表面活性剂(不易消化)的制剂。对载药 LBF 的体外脂肪分解进行了研究,并定量了溶解和沉淀药物的量。用偏光显微镜(PLM)和拉曼光谱对沉淀药物的固体形式进行了表征。与中性和酸性化合物相比,在存在消化产物的情况下,弱碱的溶解度显著增加,而弱碱的溶解度降低。溶解度的增加倍数与弱碱的离解度有关,因此与游离脂肪酸的吸引力有关。需要高水平的过饱和度才能引起沉淀。对于弱碱,剂量数表明在脂肪分解过程中不会发生沉淀;因此,这些化合物不在进一步研究中。固态分析证明丹那唑和灰黄霉素以结晶形式沉淀,而尼氯柳胺则以水合物形式沉淀。在 PLM 中可以看到非洛地平的晶体和吲哚美辛的晶体,而拉曼光谱显示存在无定形药物,表明无定形沉淀迅速结晶。将固态分析与文献数据相结合,允许分析固体形式与药物物理化学性质之间的关系。结果发现,低分子量和高熔点增加了结晶沉淀的可能性,而高分子量、低熔点和正电荷有利于形成无定形沉淀。